AIM:Our aim is to evaluate the role of Nalbuphine as an additive to Bupivacaine to increase the duration of analgesia postoperatively by epidural anaesthesia. METHODS: 60 patients randomly allocated into two groups, 30 patients in each of both sexes ranging from 18-50 yrs age group of ASA grade I and II, posted for lower abdominal surgeries using 0.2mg/kg of Nalbuphine (Made to 1ml) with 0.5% Bupivacaine 19ml in study group epidurally with control group 0.5% Bupivacaine with 1ml of normal saline. RESULT: Epidural Nalbuphine produces early onset of sensory blockade significantly at 3.23±0.97mins (Control group 15.30±2.97mins), and prolongs the duration of postoperative analgesia significantly up to 449.67±39.43mins. (Control group 185.93± 32.43mins). CONCLUSION: In conclusion epidural Nalbuphine 0.2mg/kg with 0.5% Bupivacaine produces early onset of analgesia and prolonged duration of analgesia compared with 0.5% Bupivacaine with Normal saline.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.